Gansu Longshenrongfa Pharmaceutical Industry Co Ltd (300534) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.023x

Based on the latest financial reports, Gansu Longshenrongfa Pharmaceutical Industry Co Ltd (300534) has a cash flow conversion efficiency ratio of -0.023x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-17.57 Million ≈ $-2.57 Million USD) by net assets (CN¥756.82 Million ≈ $110.75 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 300534 net asset quality index to measure how much of total assets are equity-financed.

Gansu Longshenrongfa Pharmaceutical Industry Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Gansu Longshenrongfa Pharmaceutical Industry Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Gansu Longshenrongfa Pharmaceutical Indu cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Gansu Longshenrongfa Pharmaceutical Industry Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Hailir Pesticides and Chemicals Group Co Ltd SHG:603639	0.047x
Fuxin Dare Automotive Parts Co Ltd SHE:300473	0.056x
LG Balakrishnan & Bros Limited NSE:LGBBROSLTD	0.063x
Sharda Motor Industries Limited NSE:SHARDAMOTR	0.127x
Continental Holdings Corp TW:3703	0.160x
Ur Energy Inc NYSE MKT:URG	-0.166x
SA Corporate Real Estate Fund Managers Ltd JSE:SAC	0.023x
Mesa Laboratories Inc NASDAQ:MLAB	0.100x

Annual Cash Flow Conversion Efficiency for Gansu Longshenrongfa Pharmaceutical Industry Co Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see 300534 stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥781.08 Million ≈ $114.30 Million	CN¥-6.54 Million ≈ $-956.57K	-0.008x	-103.58%
2024-12-31	CN¥727.93 Million ≈ $106.52 Million	CN¥170.14 Million ≈ $24.90 Million	0.234x	+72.29%
2023-12-31	CN¥711.51 Million ≈ $104.12 Million	CN¥96.53 Million ≈ $14.12 Million	0.136x	+806.01%
2022-12-31	CN¥763.13 Million ≈ $111.67 Million	CN¥11.43 Million ≈ $1.67 Million	0.015x	-78.54%
2021-12-31	CN¥732.84 Million ≈ $107.24 Million	CN¥51.13 Million ≈ $7.48 Million	0.070x	+18.56%
2020-12-31	CN¥739.13 Million ≈ $108.16 Million	CN¥43.50 Million ≈ $6.37 Million	0.059x	+54.16%
2019-12-31	CN¥738.88 Million ≈ $108.12 Million	CN¥28.21 Million ≈ $4.13 Million	0.038x	+168.93%
2018-12-31	CN¥720.83 Million ≈ $105.48 Million	CN¥10.23 Million ≈ $1.50 Million	0.014x	+592.28%
2017-12-31	CN¥712.19 Million ≈ $104.22 Million	CN¥-2.05 Million ≈ $-300.53K	-0.003x	-115.45%
2016-12-31	CN¥703.74 Million ≈ $102.98 Million	CN¥13.14 Million ≈ $1.92 Million	0.019x	-75.26%
2015-12-31	CN¥405.57 Million ≈ $59.35 Million	CN¥30.60 Million ≈ $4.48 Million	0.075x	-29.77%
2014-12-31	CN¥363.10 Million ≈ $53.13 Million	CN¥39.01 Million ≈ $5.71 Million	0.107x	-4.61%
2013-12-31	CN¥318.92 Million ≈ $46.67 Million	CN¥35.92 Million ≈ $5.26 Million	0.113x	-45.79%
2012-12-31	CN¥171.46 Million ≈ $25.09 Million	CN¥35.62 Million ≈ $5.21 Million	0.208x	-7.30%
2011-12-31	CN¥45.35 Million ≈ $6.64 Million	CN¥10.16 Million ≈ $1.49 Million	0.224x	--

About Gansu Longshenrongfa Pharmaceutical Industry Co Ltd

SHE:300534 China Drug Manufacturers - Specialty & Generic

Market Cap

$534.44 Million

CN¥3.65 Billion CNY

Market Cap Rank

#11644 Global

#3185 in China

Share Price

CN¥12.04

Change (1 day)

+20.04%

52-Week Range

CN¥6.95 - CN¥12.09

All Time High

CN¥29.78